Literature DB >> 19116134

Suppression of endothelial t-PA expression by prolonged high laminar shear stress.

Erik Ulfhammer1, Maria Carlström, Niklas Bergh, Pia Larsson, Lena Karlsson, Sverker Jern.   

Abstract

Primary hypertension is associated with an impaired capacity for acute release of endothelial tissue-type plasminogen activator (t-PA), which is an important local protective response to prevent thrombus extension. As hypertensive vascular remodeling potentially results in increased vascular wall shear stress, we investigated the impact of shear on regulation of t-PA. Cultured human endothelial cells were exposed to low (< or =1.5 dyn/cm(2)) or high (25 dyn/cm(2)) laminar shear stress for up to 48 h in two different experimental models. Using real-time RT-PCR and ELISA, shear stress was observed to time and magnitude-dependently suppress t-PA transcript and protein secretion to approximately 30% of basal levels. Mechanistic experiments revealed reduced nuclear protein binding to the t-PA specific CRE element (EMSA) and an almost completely abrogated shear response with pharmacologic JNK inhibition. We conclude that prolonged high laminar shear stress suppresses endothelial t-PA expression and may therefore contribute to the enhanced risk of arterial thrombosis in hypertensive disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116134     DOI: 10.1016/j.bbrc.2008.12.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.

Authors:  Wilhelm Ridderstråle; Ott Saluveer; Maria Carlström; Sverker Jern; Thórdís J Hrafnkelsdóttir
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

Review 2.  The effects of acute and chronic exercise on the vasculature.

Authors:  J J Whyte; M Harold Laughlin
Journal:  Acta Physiol (Oxf)       Date:  2010-03-26       Impact factor: 6.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.